Cricket-Stokes likely to start IPL as specialist batter, says Hussey
March 29 (Reuters) -England captain Ben Stokes is set to start his Indian Premier League (IPL) campaign with the Chennai Super Kings as a specialist batter after having an injection in his troublesome left knee, the team's batting coach Mike Hussey said.
With the Ashes series against Australia less than three months away the all-rounder had a cortisone injection, which can help relieve pain and inflammation, before the start of the IPL season.
The knee issue has long bothered Stokes, 31, and it had him grimacing in pain throughout the drawn two-test series with New Zealand. He bowled only two overs in England's one-run defeat in the second test.
"My understanding is he's ready to go as a batsman from the start. The bowling might be wait and see," former Australia batter Hussey told cricket news website Cricinfo on Tuesday.
"I know he had his first very light bowl this week since he had his injections in his knee. The physios from Chennai and the ECB (England & Wales Cricket Board) are working pretty closely together.
"My understanding is he won't be bowling much at all in the first few games of the tournament ... it might be a few weeks. I'm not 100% sure, (but we will) hopefully get him bowling at some stage in the tournament."
Stokes has already said he will leave the IPL early to prepare for a one-off test against Ireland at Lord's from June 1 and the first Ashes test at Edgbaston, which starts on June 16.
Four-times champions Chennai will face defending champions Gujarat Titans in the IPL season-opener on Friday.
Reporting by Pearl Josephine Nazare in Bengaluru; Editing by Peter Rutherford
免責聲明: XM Group提供線上交易平台的登入和執行服務，允許個人查看和/或使用網站所提供的內容，但不進行任何更改或擴展其服務和訪問權限，並受以下條款與條例約束：（i）條款與條例；（ii）風險提示；（iii）完全免責聲明。網站內部所提供的所有資訊，僅限於一般資訊用途。請注意，我們所有的線上交易平台內容並不構成，也不被視為進入金融市場交易的邀約或邀請 。金融市場交易會對您的投資帶來重大風險。
所有缐上交易平台所發佈的資料，僅適用於教育/資訊類用途，不包含也不應被視爲適用於金融、投資稅或交易相關諮詢和建議，或是交易價格紀錄，或是任何金融商品或非應邀途徑的金融相關優惠的交易邀約或邀請。
本網站的所有XM和第三方所提供的内容，包括意見、新聞、研究、分析、價格其他資訊和第三方網站鏈接，皆爲‘按原狀’，並作爲一般市場評論所提供，而非投資建議。請理解和接受，所有被歸類為投資研究範圍的相關内容，並非爲了促進投資研究獨立性，而根據法律要求所編寫，而是被視爲符合營銷傳播相關法律與法規所編寫的内容。請確保您已詳讀並完全理解我們的非獨立投資研究提示和風險提示資訊，相關詳情請點擊 這裡查看。
